Management of punding in Parkinson's disease: An open-label prospective study

Journal of Neurology

Volumn 258, Issue 4, 2011, Pages 656-660

  Fasano, A ^a,b   Ricciardi, L ^c   Pettorruso, M ^a   Bentivoglio, A R ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS NEUROMED   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

Amantadine; Parkinson's disease; Punding; Therapy

Indexed keywords

AMANTADINE; CITALOPRAM; CLOZAPINE; DULOXETINE; ENTACAPONE; ESCITALOPRAM; LEVODOPA; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE; SELEGILINE; SERTRALINE; TOLCAPONE;

ADULT; AGED; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; DRUG EFFICACY; DYSKINESIA; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PUNDING; QUALITY OF LIFE; STEREOTYPY;

ADULT; AGED; ALGORITHMS; AMANTADINE; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PROSPECTIVE STUDIES; STEREOTYPIC MOVEMENT DISORDER;

EID: 79953811687     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5817-8     Document Type: Article

References (19)

1. Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, Lawrence AD, Lees AJ (2004) Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397-405 (Pubitemid 38559642)
2. Fasano A, Petrovic I (2010) Insights into pathophysiology of punding reveal possible treatment strategies. Mol Psychiatry 15:560-573
3. Rylander G (1972) Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatr Neurol Neurochir 75:203-212
4. Fasano A, Barra A, Nicosia P, Rinaldi F, Bria P, Bentivoglio AR, Tonioni F (2008) Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding. Drug Alcohol Depend 96:178-182
5. Friedman JH (1994) Punding on levodopa. Biol Psychiatry 36:350-351
6. Fernandez HH, Friedman JH (1999) Punding on L-dopa. Mov Disord 14:836-838
7. (2002) Amantadine and other antiglutamate agents: management of Parkinson's disease. Mov Disord 17 (Suppl 4):13-22
8. Kashihara K, Imamura T (2008) Amantadine may reverse punding in Parkinson's disease-observation in a patient. Mov Disord 23:129-130 (Pubitemid 351281231)
9. Jankovic J (2005) Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord 20 (Suppl 11):11-16
10. Silveira-Moriyama L, Evans AH, Katzenschlager R, Lees AJ (2006) Punding and dyskinesias. Mov Disord 21:2214-2217 (Pubitemid 46140441)
11. Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33-39 (Pubitemid 29046907)
12. Aubert I, Guigoni C, Hakansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E (2005) Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann Neurol 57:17-26 (Pubitemid 40053311)
13. Kimber TE, Thompson PD, Kiley MA (2008) Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease. J Clin Neurosci 15:205-208 (Pubitemid 50009897)
14. Kalivas PW (2009) The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10:561-572
15. Thomas A, Bonanni L, Gambi F, Di Iorio A, Onofrj M (2010) Pathological gambling in PD is reduced by amantadine. Ann Neurol (in press)
16. Fasano A, Elia AE, Soleti F, Guidubaldi A, Bentivoglio AR (2006) Punding and computer addiction in Parkinson's disease. Mov Disord 21:1217-1218 (Pubitemid 44336611)
17. Miwa H, Morita S, Nakanishi I, Kondo T (2004) Stereotyped behaviors or punding after quetiapine administration in Parkinson's disease. Parkinsonism Relat Disord 10:177-180 (Pubitemid 38251663)
18. Durif F, Vidailhet M, Assal F, Roche C, Bonnet AM, Agid Y (1997) Low-dose clozapine improves dyskinesias in Parkinson's disease. Neurology 48:658-662 (Pubitemid 27120102)
19. Fasano A, Pettorruso M, Ricciardi L, Conte G, Bentivoglio AR (2010) Punding in Parkinson's disease: the impact of patient's awareness on diagnosis. Mov Disord 25:1297-1299